Lynda Charters

Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

Proteins common to Alzheimer disease play a significant role in glaucoma

Researchers investigated patients' ability to drive and work following eye injury

A case study emphasises the shifting paradigm in clinical best practices

Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases

Mentorship, leadership and addressing bias are key areas for improvement

The kidney and eye are structurally similar and the diseases of the organs may present via common pathways

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

Patient age is significant in the long-term effect of orthokeratology lenses

How this treatment paradigm could change ocular cell therapy

Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference

EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants

Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging

Enhanced detection and diagnosis of common and severe diseases

The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting

The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System

Postoperative outcomes of the tissues obtained from these donors were satisfactory

Investigators advised that further studies should be conducted to understand more precisely the benefits and risks

Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry

Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)

Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

Moving toward eliminating drug and chemical safety testing in animals

Bilateral distribution of the transgene seen with unilateral injection

Investigators sought to estimate the costs of treating GA with pegcetacoplan and to identify possible utility measures to compare treatments for GA

Data demonstrated that spontaneous macular hole closure and surgical treatment in paediatric patients appeared to be associated with comparable rates of closure and visual outcomes